NcRNAs: A synergistically antiapoptosis therapeutic tool in Alzheimer's disease
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14476 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Liangxian Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Respiratory Disease, Affiliated Hospital of Guilin Medical University, Guilin, China. Hauptthemen laut MEDLINE: Alzheimer Disease, MicroRNAs, RNA, Long Noncoding. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Project Program of Guangxi Key Laboratory of Brain and Cognitive Neuroscience (GKLBCN-20190103, GKLBCN-20190105-04, and GKLBCN-202106-02), Young and Middle aged Teachers' Basic Research Ability Improvement Project of Universities in Guangxi (2023KY0522 and 2023KY0541).
Themen: Demenz
Abstract (Originalsprache)
Aims
The aim of this review is to systematically summarize and analyze the noncoding RNAs (ncRNAs), especially microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), in the cell apoptosis among Alzheimer's disease (AD) in recent years to demonstrate their value in the diagnosis and treatment of AD.
Methods
We systematically summarized in vitro and in vivo studies focusing on the ncRNAs in the regulation of cell apoptosis among AD in PubMed, ScienceDirect, and Google Scholar.
Results
We discover three patterns of ncRNAs (including ‘miRNA‐mRNA’, ‘lncRNA‐miRNA‐mRNA’, and ‘circRNA‐miRNA‐mRNA’) form the ncRNA‐based regulatory networks in regulating cell apoptosis in AD.
Conclusions
This review provides a future diagnosis and treatment strategy for AD patients based on ncRNAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Respiratory Disease, Affiliated Hospital of Guilin Medical University, Guilin, China.
- Guangxi Key Laboratory of Brain and Cognitive Neuroscience, Guilin Medical University, Guilin, China.
- Key Laboratory of Respiratory Diseases, Education Department of Guangxi Zhuang Autonomous Region, Guilin, China.
ORCID-Profile: Bo Xiao
Förderung
- Open Project Program of Guangxi Key Laboratory of Brain and Cognitive Neuroscience (GKLBCN-20190103, GKLBCN-20190105-04, and GKLBCN-202106-02)
- Young and Middle aged Teachers' Basic Research Ability Improvement Project of Universities in Guangxi (2023KY0522 and 2023KY0541)
Zitieren
APA
Li, L., Jin, M., Tan, J., & Xiao, B. (2024). NcRNAs: A synergistically antiapoptosis therapeutic tool in Alzheimer's disease. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14476
Vancouver
Li L, Jin M, Tan J, Xiao B. NcRNAs: A synergistically antiapoptosis therapeutic tool in Alzheimer's disease. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14476
BibTeX
@article{Li2024,
author = {Li, Liangxian and Jin, Mingyue and Tan, Jie and Xiao, Bo},
title = {NcRNAs: A synergistically antiapoptosis therapeutic tool in Alzheimer's disease},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14476}
}
EUVIMED